See also this year's filing and all EDGAR filings for this company.
PDF Report 0001341235_2022_Aldeyra_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001341235', 'EntityCommonStockSharesOutstanding': 58098965, 'Assets': 233137120, 'AssetsCurrent': 232752770, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 27401597, 'LiabilitiesAndStockholdersEquity': 233137120, 'LiabilitiesCurrent': 11772662, 'LiabilitiesNoncurrent': 15628935, 'NetIncome': -57776274, 'PropertyPlantAndEquipmentNet': 32487, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 351863, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 205735523, 'remainder_NetIncome': -57776274, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001341235')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Edgar->Model Mapping
